Clinical Trial Details Page

EA2165

Objective

Nivolumab after Combined Modlity Therapy in Treating Patients with High Risk Stage II-IIIB Anal Cancer. For more information contact Nancy Burns at 919-784-7209.

IRB Protocol Number
CT03233711

Clinical Trial Categories

  • Miscellaneous Studies
Contact
Nancy Burns at 919-784-7209
or Nancy.Burns2@unchealth.unc.edu
How to Participate

View eligibility criteria and additional study information.

Related Locations